Medivation Signs Non-Disclosure Pacts With Pfizer, Amgen -Reuters
10 May 2016 - 4:18AM
Dow Jones News
Medivation Inc. (MDVN) has decided to explore a sale, Reuters
reported Monday, citing people familiar with the matter.
The biopharmaceutical company recently rejected a takeover
approach from Sanofi SA (SNY, SAN.FR).
According to the Reuters report, Medivation has signed
non-disclosure agreements with Pfizer Inc. (PFE) and Amgen Inc.
(AMGN).
Medivation shares recently traded up 4.2% to $62.50.
Full story at
http://www.reuters.com/article/us-medivation-m-a-exclusive-idUSKCN0Y020U
Write to nymonitoring@dowjones.com
(END) Dow Jones Newswires
May 09, 2016 14:03 ET (18:03 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Amgen (NASDAQ:AMGN)
Historical Stock Chart
From Apr 2024 to May 2024
Amgen (NASDAQ:AMGN)
Historical Stock Chart
From May 2023 to May 2024